Journal article
A153 MEASURING QUALITY OF LIFE AND DISEASE ACTIVITY IN PEDIATRIC PATIENTS RECEIVING INDUCTION THERAPY OF EXCLUSIVE ENTERAL NUTRITION OR CORTICOSTEROIDS FOR ACTIVE INFLAMMATORY BOWEL DISEASE
Abstract
Abstract
Background
Inflammatory bowel disease (IBD) is a chronic illness that can affect a child’s physical, social and psychological well-being. Studies have shown that active IBD is associated with lower quality of life (QOL) scores in children. Exclusive enteral nutrition (EEN) and corticosteroids (CS) are effective treatment options for induction of remission in pediatric Crohn’s disease (CD), while CS is effective for ulcerative colitis …Authors
Hart L; Farbod Y; Halgren CR; Mbuagbaw L; Zachos M; Pai N
Journal
Journal of the Canadian Association of Gastroenterology, Vol. 1, No. Suppl 1, pp. 264–265
Publication Date
February 2018
ISSN
2515-2084